Claims
- 1. An isolated protein comprising a polypeptide consisting of SEQ ID NO:2.
- 2. A composition comprising the isolated protein of claim 1 and a pharmaceutically acceptable carrier.
- 3. An isolated fusion protein comprising a heterologous amino acid sequence fused to the polypeptide of claim 1.
- 4. A composition comprising the isolated fusion protein of claim 3 and a pharmaceutically acceptable carrier.
- 5. The isolated protein of claim 1, wherein the isolated protein consists of the polypeptide.
- 6. A composition comprising the isolated protein of claim 5 and a pharmaceutically acceptable carrier.
RELATED APPLICATIONS
This Application is a Divisional Application of Ser. No. 08/934,846, filed on Sep. 22, 1997, now U.S. Pat. No. 5,882,898, which claims the benefit of U.S. Provisional Patent Application Ser. No. 60/058,024, filed on Aug. 29, 1997.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5565204 |
Kuo et al. |
Oct 1996 |
|
Non-Patent Literature Citations (7)
Entry |
Lazar Mol Cell Biol 8(3):1247-1252, 1988. |
Burgess J Cell Biol 111:2129-2138, 1990. |
Jazin Reg Pept 47:247-258, 1993. |
Rudinger Peptide Hormones Edited by Parsons NIMR, London, 1976. |
Herzog DNA Cell Biol 12(6):465-471, 1993. |
Eddy ATCC No.: Organism (6301-6312) (Public Health Rep. 59:449-468 ATCC Catalogue 17 Edition, p. 208, 1989. |
Lopez, et. al..,GenBank Submission, Accession No. U16156, M17362, M58706, "Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme." |
Divisions (1)
|
Number |
Date |
Country |
Parent |
934846 |
Sep 1997 |
|